Comments
Loading...
Enanta Pharma Earnings Estimates, EPS & Revenue | NASDAQ:ENTA | Benzinga
Enanta Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS
$-1.060
Quarterly Revenue
$14.93M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$64.46M
Analyze the earnings history of Enanta Pharma using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTA | Enanta Pharma | -$1.07 | — | — | — | $17.97M | — | — | — | 08/04/2025 | Get Alert |
| ENTA | Enanta Pharma | -$1.47 | -$1.46 | -$1.06 | 27.40% | $17.05M | $15.94M | $14.93M | -6.36% | 05/12/2025 | Get Alert |
| ENTA | Enanta Pharma | -$1.58 | -$1.35 | -$1.05 | 22.22% | $18.00M | $17.25M | $16.96M | -1.69% | 02/10/2025 | Get Alert |
| ENTA | Enanta Pharma | -$1.33 | -$1.41 | -$1.36 | 3.55% | $18.93M | $16.07M | $14.61M | -9.10% | 11/25/2024 | Get Alert |
| ENTA | Enanta Pharma | -$1.86 | -$1.45 | -$1.07 | 26.21% | $18.89M | $17.18M | $17.97M | 4.60% | 08/05/2024 | Get Alert |
| ENTA | Enanta Pharma | -$1.79 | -$1.33 | -$1.47 | -10.53% | $17.80M | $16.52M | $17.05M | 3.23% | 05/06/2024 | Get Alert |
| ENTA | Enanta Pharma | -$1.39 | -$1.19 | -$1.58 | -32.77% | $23.59M | $21.28M | $18.00M | -15.40% | 02/07/2024 | Get Alert |
| ENTA | Enanta Pharma | -$1.27 | -$2.00 | -$1.33 | 33.50% | $20.32M | $17.50M | $18.93M | 8.20% | 11/20/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.53 | -$2.33 | -$1.86 | 20.17% | $19.48M | $18.06M | $18.89M | 4.61% | 08/07/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.63 | -$1.98 | -$1.79 | 9.60% | $18.72M | $19.18M | $17.80M | -7.22% | 05/08/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.48 | -$1.59 | -$1.39 | 12.58% | $27.65M | $22.57M | $23.59M | 4.50% | 02/07/2023 | Get Alert |
| ENTA | Enanta Pharma | -$1.22 | -$1.35 | -$1.27 | 5.93% | $23.57M | $22.86M | $20.32M | -11.12% | 11/21/2022 | Get Alert |
| ENTA | Enanta Pharma | -$1.19 | -$1.39 | -$1.53 | -10.07% | $21.62M | $20.70M | $19.48M | -5.90% | 08/08/2022 | Get Alert |
| ENTA | Enanta Pharma | -$1.09 | -$1.43 | -$1.63 | -13.99% | $20.13M | $20.67M | $18.72M | -9.45% | 05/09/2022 | Get Alert |
| ENTA | Enanta Pharma | -$0.41 | -$1.09 | -$1.48 | -35.78% | $31.74M | $27.44M | $27.65M | 0.76% | 02/08/2022 | Get Alert |
| ENTA | Enanta Pharma | -$1.46 | -$1.22 | -$1.22 | 0.00% | $23.63M | $26.34M | $23.57M | -10.50% | 11/22/2021 | Get Alert |
| ENTA | Enanta Pharma | -$0.71 | -$1.26 | -$1.19 | 5.56% | $18.65M | $22.14M | $21.62M | -2.33% | 08/05/2021 | Get Alert |
| ENTA | Enanta Pharma | -$0.30 | -$0.97 | -$1.09 | -12.37% | $27.62M | $24.85M | $20.13M | -18.99% | 05/06/2021 | Get Alert |
| ENTA | Enanta Pharma | $0.65 | -$0.74 | -$0.41 | 44.59% | $52.57M | $28.79M | $31.74M | 10.26% | 02/08/2021 | Get Alert |
| ENTA | Enanta Pharma | $0.44 | -$0.95 | -$1.46 | -53.68% | $51.31M | $25.74M | $23.63M | -8.19% | 11/23/2020 | Get Alert |
| ENTA | Enanta Pharma | $0.33 | -$0.77 | -$0.71 | 7.79% | $44.37M | $27.89M | $18.65M | -33.12% | 08/04/2020 | Get Alert |
Enanta Pharma (ENTA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-05-12 | $-1.06 | $-1.46 | 27.4 % |
| Q1 | 2025-02-10 | $-1.05 | $-1.35 | 22.2 % |
| Q4 | 2024-11-25 | $-1.36 | $-1.41 | 3.55 % |
| Q3 | 2024-08-05 | $-1.07 | $-1.45 | 26.2 % |
Enanta Pharma (ENTA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2025-05-12 | $14.93M | $15.94M | -6.36 % |
| Q1 | 2025-02-10 | $16.96M | $17.25M | -1.69 % |
| Q4 | 2024-11-25 | $14.61M | $16.07M | -9.10 % |
| Q3 | 2024-08-05 | $17.97M | $17.18M | 4.60 % |
FAQ
When is Enanta Pharma (NASDAQ:ENTA) reporting earnings?
Enanta Pharma (ENTA) is scheduled to report earnings on August 4, 2025. The last reported earnings were for reported on May 12, 2025 for Q2.
What were the latest earnings per share (EPS) for Enanta Pharma (NASDAQ:ENTA)?
The Actual EPS was $-1.06, which beat the estimate of $-1.46.
What were Enanta Pharma’s (NASDAQ:ENTA) revenues?
The Actual Revenue was $14.9M, which missed the estimate of $15.9M.
Browse earnings estimates, EPS, and revenue on all stocks.
